Potential confusion regarding the term 'resistance' in epidemiological surveys [9]

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 228-229

  Simjee, S ^a   Silley, P ^b   Werling, H O ^c   Bywater, R ^d  

^a ELANCO ANIMAL HEALTH   (United States)

^b MB Consult Limited   (United Kingdom)

^c BAYER PHARMA AG   (Germany)

^d Bywater Consultancy   (United Kingdom)

Author keywords

Clinical breakpoints; Epidemiological cut off values; Resistance

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CLINICAL LABORATORY; CLINICAL PRACTICE; DATA ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; EPIDEMIOLOGICAL DATA; EPIDEMIOLOGY; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFECTION; LETTER; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NOMENCLATURE; PRACTICE GUIDELINE; WILD TYPE;

DRUG RESISTANCE, MICROBIAL; EPIDEMIOLOGIC STUDIES; HUMANS; MICROBIAL SENSITIVITY TESTS; TERMINOLOGY AS TOPIC;

EID: 37549034223     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm423     Document Type: Letter

References (4)

1. Bywater R, Silley P, Simjee S. Antimicrobial breakpoints - definitions and conflicting requirements. Vet Microbiol 2006; 118: 158-9.
2. Kahlmeter G, Brown DFJ, Goldstein FW et al. European harmonisation of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003; 52: 145-8.
3. Turnidge J, Paterson DL. Setting and revising antimicrobial susceptibility breakpoints. Clin Microbiol Rev 2007; 20: 391-406.
4. MARAN 2005. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in The Netherlands in 2005. www.cidc-lelystad.wur.ni/NR/rdonlyres/7F79ACE6-0FD2-41AB-81B2- BB17FA89603C/39226/MARAN2005def.pdf.